HURA TuHURA Biosciences, Inc./NV
Nasdaq · SEC CIK 1498382 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 46 since 2021-09-22, latest 2026-05-29 16:37
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Bianco James A. | CEO, Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 16:37 | 2026-05-28 | HURA | Bianco James A. | CEO, Dir | G - Gift | $0.00 | -150.0K | 2.17M | -6% | $0 | |
| D | 2024-10-22 | 2024-10-18 | HURA | Bianco James A. | CEO, Dir | A - Grant | $0.00 | +2.32M | 2.32M | New | $0 |
| 2023-06-02 | 2023-06-01 | HURA | Hoffman Robert E. | Pres, CEO, CFO, Dir | A - Grant | $0.00 | +59.8K | 68.9K | +657% | $0 | |
| 2023-01-06 | 2023-01-05 | HURA | Brown Dennis M | CSO | W - Inherited | $0.00 | +363 | 5,302 | +7% | $0 | |
| D | 2022-08-03 | 2022-08-01 | HURA | Brown Dennis M | CSO | A - Grant | $0.00 | +240.1K | 246.9K | +3,521% | $0 |
| D | 2022-08-03 | 2022-08-01 | HURA | Hoffman Robert E. | Pres, CEO, Dir | A - Grant | $0.00 | +400.1K | 455.1K | +728% | $0 |
| D | 2022-08-03 | 2022-08-01 | HURA | Praill Anthony Scott | CFO | A - Grant | $0.00 | +240.1K | 277.3K | +646% | $0 |
| 2022-02-17 | 2022-02-15 | HURA | Hoffman Robert E. | Pres, CEO, Dir | P - Purchase | $0.47 | +55.0K | 55.0K | New | +$25.9K | |
| 2021-12-09 | 2021-12-08 | HURA | Praill Anthony Scott | CFO | P - Purchase | $0.68 | +28.7K | 37.2K | +338% | +$19.5K | |
| M | 2021-12-08 | 2021-12-06+ | HURA | Zarrabian Saiid | Head of Strategic Partnerships, Dir | P - Purchase | $0.6281 | +50.0K | 55.5K | +909% | +$31.4K |
| 2021-11-24 | 2021-11-22 | HURA | Johnson Laura L. | Dir | P - Purchase | $0.74 | +3,000 | 3,000 | New | +$2,220 |
Purchase Sale Sale after option exercise All abbreviations